These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 27501179)

  • 1. A System to Create Stable Nanoparticle Aerosols from Nanopowders.
    Ding Y; Riediker M
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-body nanoparticle aerosol inhalation exposures.
    Yi J; Chen BT; Schwegler-Berry D; Frazer D; Castranova V; McBride C; Knuckles TL; Stapleton PA; Minarchick VC; Nurkiewicz TR
    J Vis Exp; 2013 May; (75):e50263. PubMed ID: 23685643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A versatile generator of nanoparticle aerosols. A novel tool in environmental and occupational exposure assessment.
    Clemente A; Lobera MP; Balas F; Santamaria J
    Sci Total Environ; 2018 Jun; 625():978-986. PubMed ID: 29306835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
    Li X; Vogt FG; Hayes D; Mansour HM
    J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders.
    Li L; Sun S; Parumasivam T; Denman JA; Gengenbach T; Tang P; Mao S; Chan HK
    Eur J Pharm Biopharm; 2016 May; 102():132-41. PubMed ID: 26970252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of formulation and operating variables on zanamivir dry powder inhalation characteristics and aerosolization performance.
    Yang Y; Yang Z; Ren Y; Mei X
    Drug Deliv; 2014 Sep; 21(6):480-6. PubMed ID: 24491208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT; Armstrong B; Larson I; Stewart PJ; Morton DA
    Eur J Pharm Sci; 2010 Aug; 40(5):412-21. PubMed ID: 20433919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Powder Intrinsic Properties as Dustiness Predictor for an Efficient Exposure Assessment?
    Shandilya N; Kuijpers E; Tuinman I; Fransman W
    Ann Work Expo Health; 2019 Nov; 63(9):1029-1045. PubMed ID: 31587034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis.
    Eedara BB; Tucker IG; Das SC
    Int J Pharm; 2016 Jun; 506(1-2):174-83. PubMed ID: 27091294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SiO2 aerosol nanoparticle reactor for occupational health and safety studies.
    Ostraat ML; Swain KA; Krajewski JJ
    J Occup Environ Hyg; 2008 Jun; 5(6):390-8. PubMed ID: 18428032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride.
    Karimi K; Katona G; Csóka I; Ambrus R
    J Pharm Biomed Anal; 2018 Jan; 148():73-79. PubMed ID: 28965047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental methods to determine inhalability and personal sampler performance for aerosols in ultra-low windspeed environments.
    Schmees DK; Wu YH; Vincent JH
    J Environ Monit; 2008 Dec; 10(12):1426-36. PubMed ID: 19037484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generating nano-aerosols from TiO₂ (5 nm) nanoparticles showing different agglomeration states. Application to toxicological studies.
    Noël A; Cloutier Y; Wilkinson KJ; Dion C; Hallé S; Maghni K; Tardif R; Truchon G
    J Occup Environ Hyg; 2013; 10(2):86-96. PubMed ID: 23252512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Design and evaluation of an aerosol nanoparticle generation system].
    Mai HJ; Jiang JK; He ZX; Hao JM
    Huan Jing Ke Xue; 2013 Aug; 34(8):2950-4. PubMed ID: 24191534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolization, Drug Permeation and Cellular Interaction of Dry Powder Pulmonary Formulations of Corticosteroids with Hydroxypropyl-β-Cyclodextrin as a Solubilizer.
    Vartiainen V; Bimbo LM; Hirvonen J; Kauppinen EI; Raula J
    Pharm Res; 2017 Jan; 34(1):25-35. PubMed ID: 27604893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR).
    Wong J; Lin YW; Kwok PC; Niemelä V; Crapper J; Chan HK
    Mol Pharm; 2015 Sep; 12(9):3433-40. PubMed ID: 26222019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S; Schoenbrodt T; Weiler C; Friess W
    Eur J Pharm Sci; 2011 May; 43(1-2):32-40. PubMed ID: 21440061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-efficiency particulate air filter test stand and aerosol generator for particle loading studies.
    Arunkumar R; Hogancamp KU; Parsons MS; Rogers DM; Norton OP; Nagel BA; Alderman SL; Waggoner CA
    Rev Sci Instrum; 2007 Aug; 78(8):085105. PubMed ID: 17764353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of energy on propylene glycol aerosols using the capillary aerosol generator.
    Shen X; Hindle M; Byron PR
    Int J Pharm; 2004 May; 275(1-2):249-58. PubMed ID: 15081155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.